Zhonghua bing li xue za zhi = Chinese journal of pathology · 2016
[Fetal adenocarcinoma of the lung: a clinicopathologic analysis of six cases].
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang H J, Chen X Y
Аннотация
OBJECTIVE: To investigate the clinicopathologic features, diagnosis and differential diagnosis, and genetic alterations of fetal adenocarcinoma of lung (FACL).
METHODS: Six cases of FACL were collected from Fujian Provincial Hospital, the clinicopathologic features and immunophenotype were retrospectively evaluated, PAS/PASD staining and genetic mutation analysis of epidermal growth factor receptor (EGFR) were performed.
RESULTS: There were three male and three female patients, aged 40 to 75 years (median 59 years). Tumor size ranged from 2.5-6.0 cm (mean 3.8 cm). Histologically, the tumors showed classic glandular structure similar to fetal lung tubules. The neoplastic glands were lined by non-ciliated pseudostratified columnar epithelium with clear or granular cytoplasm. Some cells showed subnuclear or supranuclear vacuoles. Squamoid morules were also noted. Immunohistochemically, the tumor cells were positive for TTF1, Napsin A, CKL, and focally positive for CKH (2/6), synaptophysin (1/6), chromogranin A (1/6), CD56 (2/6), and EGFR (4/6). PAS/PASD staining was positive in the tumor cells. Five cases showed EGFR mutation, one case was of wild type. All six patients underwent surgical resection, and four had chemotherapy. All patients had no evidence of recurrence or metastasis during 1-40 months follow-up period.
CONCLUSIONS: FACL is a rare tumor with low malignant potential and has distinct morphologic feature. Clinically and pathologically, it needs to be differentiated from alveolar adenocarcinoma, adenosquamous carcinoma, pneumoblastoma, and metastatic endometrioid adenocarcinoma. The primary treatment for FACL is complete surgical excision and chemotherapy, with good outcome.
METHODS: Six cases of FACL were collected from Fujian Provincial Hospital, the clinicopathologic features and immunophenotype were retrospectively evaluated, PAS/PASD staining and genetic mutation analysis of epidermal growth factor receptor (EGFR) were performed.
RESULTS: There were three male and three female patients, aged 40 to 75 years (median 59 years). Tumor size ranged from 2.5-6.0 cm (mean 3.8 cm). Histologically, the tumors showed classic glandular structure similar to fetal lung tubules. The neoplastic glands were lined by non-ciliated pseudostratified columnar epithelium with clear or granular cytoplasm. Some cells showed subnuclear or supranuclear vacuoles. Squamoid morules were also noted. Immunohistochemically, the tumor cells were positive for TTF1, Napsin A, CKL, and focally positive for CKH (2/6), synaptophysin (1/6), chromogranin A (1/6), CD56 (2/6), and EGFR (4/6). PAS/PASD staining was positive in the tumor cells. Five cases showed EGFR mutation, one case was of wild type. All six patients underwent surgical resection, and four had chemotherapy. All patients had no evidence of recurrence or metastasis during 1-40 months follow-up period.
CONCLUSIONS: FACL is a rare tumor with low malignant potential and has distinct morphologic feature. Clinically and pathologically, it needs to be differentiated from alveolar adenocarcinoma, adenosquamous carcinoma, pneumoblastoma, and metastatic endometrioid adenocarcinoma. The primary treatment for FACL is complete surgical excision and chemotherapy, with good outcome.